Article Information
History
- September 19, 2023.
Article Versions
- Version 1 (March 14, 2023 - 06:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hilde T. Juvoddena,*,
- Dag Alnæsb,
- Ingrid Agartzc,d,e,
- Ole A. Andreassenb,e,
- Andres Serverf,
- Per M. Thorsbyg,h,
- Lars T. Westlyeb,e,i and
- Stine Knudsen-Heiera,h
- aNorwegian Centre of Expertise for Neurodevelopmental Disorders and Hypersomnias (NevSom), Department of Rare Disorders, Oslo University Hospital, Ullevål, Norway
- bNORMENT Centre, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Norway
- cNorwegian Centre for Mental Disorders Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- dDepartment of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
- eK.G. Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Norway
- fDepartment of Radiology and Nuclear medicine, Oslo University Hospital, Oslo, Norway
- gHormone Laboratory, Department of Medical Biochemistry, Biochemical Endocrinology and Metabolism Research Group, Oslo University Hospital, Aker, Norway
- hInstitute of Clinical Medicine, University of Oslo, Oslo, Norway
- iDepartment of Psychology, University of Oslo, Norway
- ↵*Correspondence to: Hilde T. Juvodden, Oslo University Hospital, Ullevål Hospital, Norwegian Centre of Expertise for Neurodevelopmental Disorders and Hypersomnias (NevSom), PO Box 4956 Nydalen, NO-0424 OSLO, Norway. Telephone number: +47 916 11 528. Email: hilde.juvodden{at}gmail.com